Eli Lilly and Company (LLY)

Index:

S&P 100

$ 919.90
   
  • Change Today:
    $-7.13
  • 52 Week High: $1,109.94
  • 52 Week Low: $625.65
  • Currency: US Dollars
  • Shares Issued: 944.80m
  • Volume: 2,671
  • Market Cap: $869,122m
  • RiskGrade: 179

Latest ShareCast News

Eli Lilly to buy Kelonia Therapeutics for up to $7bn

By Michele Maatouk

Date: Monday 20 Apr 2026

(Sharecast News) - Eli Lilly said on Monday that it has agreed to buy Boston-based Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery, for up to $7bn in cash.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 919.90
Change Today $ -7.13
% Change -0.77 %
52 Week High $1,109.94
52 Week Low $625.65
Volume 2,671
Shares Issued 944.80m
Market Cap $869,122m
RiskGrade 179

What The Brokers Say

Strong Buy 12
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 20-Apr-2026

Time Volume / Share Price
16:00 325,920 @ $919.90
16:00 146 @ $920.59
16:00 40 @ $920.58
16:00 40 @ $920.40
16:00 50 @ $920.40

Top of Page